Patricia Senet
Patricia Senet is an expert in Dermatology at Assistance Publique - Hôpitaux de Paris (France). As of January 2026, ScienceLeadR ranks Patricia Senet in the top 1% of experts worldwide for Skin Ulcer. Patricia Senet has authored 261 publications, the most recent in 2025, and is an investigator in 10 clinical trials, 1 of them ongoing. SLR score: 875 (community average: 125). How the SLR is computed.
LeadR Profile
Dermatology
Subspecialties: Rheumatology - Cardiology - Infectiology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1997 - 2026
Number : 261
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Deep hierarchical subtyping of multi-organ systemic sclerosis trajectories - a EUSTAR study. PMID 40890392 — skin, sclerosis, multiple chronic conditions, scleroderma, systemic | NPJ Digit Med | 2025 | 0 |
| Digital clubbing, an unfamiliar feature of cryopyrin-associated periodic syndrome: A cohort study. PMID 40147682 — cohort studies, dermatology, cryopyrin-associated periodic syndromes | J Am Acad Dermatol | 2025 | 0 |
| Tocilizumab for refractory and/or relapsing polyarteritis nodosa. PMID 41369608 — vasculitis, polyarteritis nodosa, therapeutics, dermatology | J Am Acad Dermatol | 2025 | 0 |
| Leg ulcers associated with tyrosine kinase inhibitors of vascular endothelial growth factor receptors. PMID 41246915 — sexually transmitted diseases, growth, vascular endothelial growth factor a, angiogenesis inhibitors, leg ulcer, ulcer, skin diseases, protein kinase inhibitors, receptors, growth factor, protein-tyrosine kinases, tyrosine, endothelial growth factors | J Eur Acad Dermatol Venereol | 2025 | 0 |
| Development and validation of LUPIN: a patient-centred self-administered tool to assess disease activity and patient-reported outcomes in systemic lupus erythematosus. PMID 40992789 — pain, rheumatic diseases, lupus erythematosus, systemic, fatigue, physicians, patient reported outcome measures | RMD Open | 2025 | 1 |
Clinical Studies 10
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 3
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Efficacy and Safety of Light Compression System in the Local Treatment of Mixed Leg Ulcers (PROMETHEE Clinical Investigation) NCT06899919 — quality of life, bandages, safety, classification, leg ulcer, ulcer, therapeutics | N/A | Recruiting | 2025 |
LeadR Networks
Main global connection map